SRPT FY 2009 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

SRPTSarepta Therapeutics, Inc.

$2B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$18M-17.3% YoY

Gross Profit

$18M100.0% margin

Operating Income

-$16M-88.2% margin

Net Income

-$25M-143.1% margin

EPS (Diluted)

$-1.62

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$60M

Total Liabilities

$36M

Stockholders' Equity

$24M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$18M	$21M	-17.3%
Gross Profit	$18M	$21M	-17.3%
Operating Income	-$16M	-$27M	+43.5%
Net Income	-$25M	-$24M	-5.0%